We recently published 10 Stocks Delivering Double-Digit Gains Effortlessly; 4 Hit Highs. Corvus Pharmaceuticals Inc.

In today’s Pharma Pulse, the United States finalizes its departure from global health oversight, while domestic providers ...

Astellas' CEO said he doesn't want to make acquisitions simply to fill a revenue gap. Takeda is preparing for Trintellix's U.S. patent expiry with a round of layoffs. | Astellas CEO said he doesn't ...

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is one of the Best Russell 2000 Stocks to Buy Right Now. On January 20, Tiago Fauth from ...

While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved ...

Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools ...

Early eczema trial success and heavy trading are rapidly reshaping how investors view this drug developer, today, Jan. 20, 2026.

USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...

Pharmaceuticals used in health care provide huge health and economic benefits to society, but are now found extensively as ...

Researchers at the University of Oulu, Finland, have developed a pine-bark–based water-treatment medium that efficiently removes antibiotics as well as residues of blood-pressure and antidepressant ...

Telix Pharmaceuticals meets its FY25 revenue target with strong Q4 growth, expanded U.S. launches and ongoing trials.